Co-Care: A Registry for Individuals at Increased Risk for Colorectal Cancer

Dylan Sperling, Lina Jandorf, Pathu Sriphanlop, Clarissa Martinez, Karen L. Brown, Emily R. Soper, Susan Hiraki, Steven H. Itzkowitz

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


INTRODUCTION: Colorectal cancer (CRC) is one of the leading causes of cancer death for both men and women in the United States. Several factors can increase one’s risk of CRC, including a personal or family history of CRC, a diagnosis or family history of a hereditary colon cancer syndrome, or a diagnosis of chronic inflammatory bowel disease. The purpose of this project was to create a colorectal cancer registry (Co-Care) for individuals with a personal or family history of CRC, and those with disorders of the colon or rectum that are associated with an increased risk for developing CRC. Methods: To be eligible for the registry, patients either had a personal or family history of CRC, a diagnosis or family history of Lynch syndrome, familial adenomatous polyposis, or a diagnosis of Crohn’s colitis or ulcerative colitis with dysplasia. Participants were recruited after seeing their gastroenterologist or genetic counselor, or after undergoing a full or partial colectomy at Mount Sinai Hospital in New York City. Eligible patients who agreed to participate were interviewed by a member of the research staff and asked a wide range of questions pertaining to CRC risk. RESULTS: A total of 224 patients were enrolled in the registry. Participants are mostly white, born in the United States, and married, with a bachelor’s or graduate degree, reporting an annual household income of $100,000 or more. The largest portion have a family history of CRC (27.2%), and almost half of participants are of Jewish descent (46.2%) and have undergone full or partial colectomy (48.2%). More than half of participants have neither received genetic counseling (54.5%) nor undergone genetic testing (59.7%). Only 3.6% report that they currently smoke cigarettes, and 41.1% consume alcohol at least once per week. Lastly, 18.3%, 10.3%, and 27.7% of participants report that they currently take aspirin, folic acid/folate pills or tablets, or calcium pills/tablets, respectively. CONCLUSIONS: This registry can improve our understanding of CRC and related diseases, and be used to design future interventions related to disease risk, prognosis, and prevention of CRC.

Original languageEnglish
Pages (from-to)11-16
Number of pages6
JournalJournal of registry management
Issue number1
StatePublished - 1 Mar 2017


  • Crohn's colitis
  • Lynch syndrome
  • cancer registry
  • colorectal cancer
  • famiial adenomatous polyposis
  • inflammatory bowel disease
  • ulcerative colitis


Dive into the research topics of 'Co-Care: A Registry for Individuals at Increased Risk for Colorectal Cancer'. Together they form a unique fingerprint.

Cite this